Since the first identification of CHD7 mutations in patients with CHARGE syndrome just over 10 years ago, clinical genetic, animal, and biochemical studies have led to important insights into the causes of CHARGE syndrome phenotypes. This evidence concerns the gene CHD7 and CHARGE syndrome.